Crystal Structure
Crystallisation Method: EM
Corresponding Chain: A
Sequence Length: 2-2377
Detail: Struture Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0541 | ||||
Gene Name | CACNA1G | ||||
Protein Name | Voltage-gated calcium channel subunit alpha Cav3.1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Crystal Structure Crystallisation Method: EM Corresponding Chain: A Sequence Length: 2-2377 Detail: Struture Info |
||||
Synonyms | Cav3.1c; NBR13; Voltage-dependent T-type calcium channel subunit alpha-1G | ||||
DT Family | Na+/K+/Ca2+ Channel Targeting Tarantula Huwentoxin (THT) Family ; | ||||
Tissue Specificity | Highly expressed in brain, in particular in the amygdala, subthalamic nuclei, cerebellum and thalamus. Moderate expression in heart; low expression in placenta, kidney and lung. Also expressed in colon and bone marrow and in tumoral cells to a lesser extent. Highly expressed in fetal brain, but also in peripheral fetal tissues as heart, kidney and lung, suggesting a developmentally regulated expression. | ||||
Function | This transporter is voltage-sensitive calcium channels (VSCC), and it mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
(δ) Xenobiotics-regulated Structural Variability |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.